We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
06 Feb 2023 - 09 Feb 2023

Biomarker-Based Blood Test Assesses Risk for Diabetic Kidney Disease Before Symptoms Appear

By LabMedica International staff writers
Posted on 06 Dec 2022
Print article
Image: NaviDKD is the first and only scientifically-proven predictive screening for diabetic kidney disease (Photo courtesy of Journey Biosciences)
Image: NaviDKD is the first and only scientifically-proven predictive screening for diabetic kidney disease (Photo courtesy of Journey Biosciences)

Diabetic kidney disease (DKD) is a serious health condition that often goes undetected until irreparable damage has been done to the kidneys and kidney function. One-in-three adults with diabetes will develop kidney disease. And, in 90% of cases, they won’t know they have it until it has advanced to the point where they need dialysis or a kidney transplant to survive, as it develops slowly and without symptoms. Now, the first and only scientifically-based screening technology provides an early read on the risk of developing kidney disease for people with diabetes, giving them and their doctors time to take preventative action and improve outcomes.

Journey Biosciences, Inc. (Lebanon, NH, USA) has launched NaviDKD, a biomarker-based blood test that proactively assesses the risk of kidney disease in people with diabetes years before clinical signs or symptoms appear. Along with its proprietary Compass reporting platform, NaviDKD provides actionable insights for preventing and managing kidney complications before they occur. NaviDKD is the first and only scientifically-proven predictive screening for DKD and provides healthcare providers with the insights needed to preserve their patients' kidney health, avoid complications, and improve outcomes.

By proactively assessing risk 10+ years in advance of clinical signs and symptoms, NaviDKD provides the opportunity to treat with therapeutics and technologies to change the outcome. By combining the simplicity of a blood test with the advanced science of predictive biomarkers, NaviDKD gives healthcare providers and their patients an early alert of their individual risk - giving a decade or more to make informed decisions that preserve their kidney health.

"For the one-in-three people with diabetes who will develop diabetic kidney disease, NaviDKD provides an opportunity to fundamentally change their ultimate health outcomes," said Adam Graybill, Chief Executive Officer of Journey Biosciences. "By identifying those at elevated or high risk of developing DKD before any symptoms or clinical indications, the conversation between doctor and patient can focus on taking proactive, preventative action instead of reacting to an unwanted diagnosis."

Related Links:
Journey Biosciences, Inc.

Gold Supplier
Chemiluminescence Immunoassay Analyzer
MAGICL 6000
New
Fecal Occult Blood Test
STANDARD F iFOB FIA
New
ELISA Plate Reader
WHY101S
New
Lateral Flow Assay Pads
POREX Sample Pads

Print article
MEDLAB - INFORMA

Channels

Molecular Diagnostics

view channel
Image: The new blood test measures stress hormone levels after heart attacks (Photo courtesy of University of Oxford)

New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims

Cardiovascular disease, one of the leading causes of death, generally manifests itself through heart attacks. Most patients with very large heart attacks are treated using an emergency procedure called... Read more

Immunology

view channel
Image: Scientists have won USD 9.5 million to study emerging pathogens (Photo courtesy of Pexels)

Study of Emerging Pathogens to Better Understand Influenza-Antibody Interactions Could Improve Diagnostics

Outbreaks of Avian influenza have occurred around the world for over a century. The highly pathogenic H5N1 virus which was first identified in 1996 can lead to severe disease and has a high fatality rate... Read more

Microbiology

view channel
Image: Medical illustration of Carbapenem-resistant Enterobacteriacea (Photo courtesy of CDC, Stephanie Rossow)

Breakthrough Test Enables Targeted Antibiotic Therapy for Various Enterobacter Species

Bacteria of the Enterobacter genus are considered to be the most dangerous bacteria linked to hospital infections across the world. Some of their representatives demonstrate high resistance to commonly-used... Read more

Technology

view channel
Image: Flexible copper sensor made cheaply from ordinary materials (Photo courtesy of University of São Paulo)

Low-Cost Portable Sensor Detects Heavy Metals in Sweat

Heavy metals like lead and cadmium can be found in batteries, cosmetics, food and many other things that have become a part of daily life. However, they become toxic if they accumulate in the human body... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.